APOE and dementia: In our MCI population with CSF Aβ42 levels within the normal range, APOE ε4 showed similar predictive value to that of Aβ42 for short-term progression to dementia, suggesting that APOE genotyping could potentially be incorporated in the risk assessment in this patient population.